IL6 and craniosynostosis: The level of IL-6 was 275.7 pg/mg protein ± 15.3 pg/mg protein in the MCAO-Con group (##p < 0.01 vs. Sham-Con group), and CSO treatment significantly decreased the level of IL-6 to 123.3 pg/mg protein ± 10.1 pg/mg protein (*p < 0.05 vs. MCAO-Con group).